Packer, M., Anker, S. D., Butler, J., Filippatos, G., Pocock, S. J., Carson, P., . . . Zannad, F. (2020). Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure. The New England journal of medicine, 383(15), 1413-1424. https://doi.org/10.1056/NEJMoa2022190
Citace podle Chicago (17th ed.)Packer, Milton, et al. "Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure." The New England Journal of Medicine 383, no. 15 (2020): 1413-1424. https://doi.org/10.1056/NEJMoa2022190.
Citace podle MLA (9th ed.)Packer, Milton, et al. "Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure." The New England Journal of Medicine, vol. 383, no. 15, 2020, pp. 1413-1424, https://doi.org/10.1056/NEJMoa2022190.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..